Literature DB >> 11735635

Pyelonephritis in pregnancy: treatment options for optimal outcomes.

D A Wing1.   

Abstract

Acute pyelonephritis is one of the most common indications for antepartum hospitalisation. When acute pyelonephritis is diagnosed, conventional treatment includes intravenous fluid and parenteral antibacterial administration. There are limited data by which to assess the superiority of one antibacterial regimen over the other in terms of efficacy, patient acceptance and safety for the developing fetus. There is a small body of evidence to support the ambulatory treatment of pregnant women with pyelonephritis in the first and early second trimesters.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11735635     DOI: 10.2165/00003495-200161140-00006

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  51 in total

1.  Comparison of ciprofloxacin (7 days) and trimethoprim-sulfamethoxazole (14 days) for acute uncomplicated pyelonephritis pyelonephritis in women: a randomized trial.

Authors:  D A Talan; W E Stamm; T M Hooton; G J Moran; T Burke; A Iravani; J Reuning-Scherer; D A Church
Journal:  JAMA       Date:  2000 Mar 22-29       Impact factor: 56.272

2.  Pulmonary injury associated with antepartum pyelonephritis: can patients at risk be identified?

Authors:  C V Towers; C M Kaminskas; T J Garite; M P Nageotte; W Dorchester
Journal:  Am J Obstet Gynecol       Date:  1991-04       Impact factor: 8.661

Review 3.  Virulence factors in Escherichia coli urinary tract infection.

Authors:  J R Johnson
Journal:  Clin Microbiol Rev       Date:  1991-01       Impact factor: 26.132

4.  Gentamicin levels in pregnant women with pyelonephritis.

Authors:  J M Graham; J D Blanco; B T Oshiro; K P Magee
Journal:  Am J Perinatol       Date:  1994-01       Impact factor: 1.862

5.  Mannose-resistant haemagglutination and P antigen recognition are characteristic of Escherichia coli causing primary pyelonephritis.

Authors:  V Väisänen; J Elo; L G Tallgren; A Siitonen; P H Mäkelä; C Svanborg-Edén; G Källenius; S B Svenson; H Hultberg; T Korhonen
Journal:  Lancet       Date:  1981 Dec 19-26       Impact factor: 79.321

6.  Pyelonephritis in pregnancy. The role of in-hospital management and nitrofurantoin suppression.

Authors:  J P Van Dorsten; R R Lenke; B S Schifrin
Journal:  J Reprod Med       Date:  1987-12       Impact factor: 0.142

7.  Pyelonephritis in pregnancy: a prospective randomized trial to prevent recurrent disease evaluating suppressive therapy with nitrofurantoin and close surveillance.

Authors:  R R Lenke; J P VanDorsten; B S Schifrin
Journal:  Am J Obstet Gynecol       Date:  1983-08-15       Impact factor: 8.661

8.  Management of acute pyelonephritis in an emergency department observation unit.

Authors:  R S Israel; S R Lowenstein; J A Marx; J Koziol-McLain; L Svoboda; S Ranniger
Journal:  Ann Emerg Med       Date:  1991-03       Impact factor: 5.721

9.  Mechanisms of hemolysis and anemia associated with acute antepartum pyelonephritis.

Authors:  S M Cox; P Shelburne; R Mason; S Guss; F G Cunningham
Journal:  Am J Obstet Gynecol       Date:  1991-02       Impact factor: 8.661

10.  Clinical trial of the outpatient management of pyelonephritis in pregnancy.

Authors:  A M Brooks; T J Garite
Journal:  Infect Dis Obstet Gynecol       Date:  1995
View more
  9 in total

1.  A novel molecular microbiologic technique for the rapid diagnosis of microbial invasion of the amniotic cavity and intra-amniotic infection in preterm labor with intact membranes.

Authors:  Roberto Romero; Jezid Miranda; Tinnakorn Chaiworapongsa; Piya Chaemsaithong; Francesca Gotsch; Zhong Dong; Ahmed I Ahmed; Bo Hyun Yoon; Sonia S Hassan; Chong Jai Kim; Steven J Korzeniewski; Lami Yeo
Journal:  Am J Reprod Immunol       Date:  2014-01-13       Impact factor: 3.886

Review 2.  Acute pyelonephritis among adults: cost of illness and considerations for the economic evaluation of therapy.

Authors:  Patricia Brown; Moran Ki; Betsy Foxman
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

Review 3.  Pyelonephritis in pregnancy: an update on treatment options for optimal outcomes.

Authors:  Jennifer A Jolley; Deborah A Wing
Journal:  Drugs       Date:  2010-09-10       Impact factor: 9.546

4.  A new anti-microbial combination prolongs the latency period, reduces acute histologic chorioamnionitis as well as funisitis, and improves neonatal outcomes in preterm PROM.

Authors:  JoonHo Lee; Roberto Romero; Sun Min Kim; Piya Chaemsaithong; Chan-Wook Park; Joong Shin Park; Jong Kwan Jun; Bo Hyun Yoon
Journal:  J Matern Fetal Neonatal Med       Date:  2015-09-16

5.  Antimicrobial Selection in the Treatment of Pyelonephritis.

Authors:  Patricia D Brown
Journal:  Curr Infect Dis Rep       Date:  2004-12       Impact factor: 3.725

6.  Optimization and validation of two multiplex qPCR assays for the rapid detection of microorganisms commonly invading the amniotic cavity.

Authors:  Andrew D Winters; Roberto Romero; Emma Graffice; Nardhy Gomez-Lopez; Eunjung Jung; Tomi Kanninen; Kevin R Theis
Journal:  J Reprod Immunol       Date:  2021-12-08       Impact factor: 4.054

7.  Maternal serum concentrations of the chemokine CXCL10/IP-10 are elevated in acute pyelonephritis during pregnancy.

Authors:  Francesca Gotsch; Roberto Romero; Jimmy Espinoza; Juan Pedro Kusanovic; Shali Mazaki-Tovi; Offer Erez; Nandor Gabor Than; Samuel Edwin; Moshe Mazor; Bo Hyan Yoon; Sonia S Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2007-10

8.  Diagnostic and treatment difficulties of pyelonephritis in pregnancy in resource-limited settings.

Authors:  Rose McGready; Vanaporn Wuthiekanun; Elizabeth A Ashley; Saw Oo Tan; Mupawjay Pimanpanarak; Samuel Jacher Viladpai-Nguen; Wilarat Jesadapanpong; Stuart D Blacksell; Stephane Proux; Nicholas P Day; Pratap Singhasivanon; Nicholas J White; François Nosten; Sharon J Peacock
Journal:  Am J Trop Med Hyg       Date:  2010-12       Impact factor: 2.345

9.  Microbial burden and inflammasome activation in amniotic fluid of patients with preterm prelabor rupture of membranes.

Authors:  Kevin R Theis; Roberto Romero; Kenichiro Motomura; Jose Galaz; Andrew D Winters; Percy Pacora; Derek Miller; Rebecca Slutsky; Violetta Florova; Dustyn Levenson; Robert Para; Aneesha Varrey; Marian Kacerovsky; Chaur-Dong Hsu; Nardhy Gomez-Lopez
Journal:  J Perinat Med       Date:  2020-02-25       Impact factor: 2.716

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.